Showing results (141-150 of 151) with videos related to
Sort By:
Pageof 16
JAMA|June 6, 2022
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical TrialEthan Basch, Deborah Schrag, Sydney Henson, et al.JAMA Oncology|January 18, 2024
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical TrialCynthia X Ma, Vera J Suman, Souzan Sanati, et al.Cancer Cell|November 18, 2022
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.Genome Research|January 30, 2019
The circular RNome of primary breast cancerMarcel Smid, Saskia M Wilting, Katharina Uhr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2020
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer CareNathan A Pennell, Melissa Dillmon, Laura A Levit, et al.Nature|November 3, 2015
Tumour exosome integrins determine organotropic metastasisAyuko Hoshino, Bruno Costa-Silva, Tang-Long Shen, et al.JAMA|December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical TrialE Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.Nature Communications|September 27, 2016
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltrationMarcel Smid, F Germán Rodríguez-González, Anieta M Sieuwerts, et al.JAMA Network Open|July 23, 2026
Characteristics of Gender-Diverse Patients With Breast CancerChandler S Cortina, Ruta Brazauskas, Meghan R Flanagan, et al.The Lancet. Oncology|December 25, 2025
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort studyGiacomo Montagna, Michael Alvarado, Sara Myers, et al.Pageof 16